- Home
- MBRX vs PCLA Comparison
MBRX vs PCLA Comparison
Compare MBRX & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- PCLA
- Stock Information
- Founded
- MBRX 2015
- PCLA 2008
- Country
- MBRX United States
- PCLA Japan
- Employees
- MBRX N/A
- PCLA N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- PCLA Building Products
- Sector
- MBRX Health Care
- PCLA Consumer Discretionary
- Exchange
- MBRX Nasdaq
- PCLA Nasdaq
- Market Cap
- MBRX 17.1M
- PCLA 14.2M
- IPO Year
- MBRX 2016
- PCLA 2025
- Fundamental
- Price
- MBRX $0.68
- PCLA $0.50
- Analyst Decision
- MBRX Strong Buy
- PCLA
- Analyst Count
- MBRX 3
- PCLA 0
- Target Price
- MBRX $5.33
- PCLA N/A
- AVG Volume (30 Days)
- MBRX 2.6M
- PCLA 731.6K
- Earning Date
- MBRX 08-12-2025
- PCLA 01-01-0001
- Dividend Yield
- MBRX N/A
- PCLA N/A
- EPS Growth
- MBRX N/A
- PCLA N/A
- EPS
- MBRX N/A
- PCLA N/A
- Revenue
- MBRX N/A
- PCLA $5,475,228.00
- Revenue This Year
- MBRX N/A
- PCLA N/A
- Revenue Next Year
- MBRX N/A
- PCLA N/A
- P/E Ratio
- MBRX N/A
- PCLA N/A
- Revenue Growth
- MBRX N/A
- PCLA 40.19
- 52 Week Low
- MBRX $0.25
- PCLA $0.37
- 52 Week High
- MBRX $3.65
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- MBRX 53.28
- PCLA N/A
- Support Level
- MBRX $0.62
- PCLA N/A
- Resistance Level
- MBRX $0.70
- PCLA N/A
- Average True Range (ATR)
- MBRX 0.07
- PCLA 0.00
- MACD
- MBRX -0.00
- PCLA 0.00
- Stochastic Oscillator
- MBRX 61.43
- PCLA 0.00
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.